Tag: unique_pharmaceutical_laboratories

Antihistamine Recall Issued Over Ranitidine Contamination Risk

21 Jul 2026 10:53 a.m. · Source: US Food and Drug Administration

Unique Pharmaceutical Laboratories is recalling Cetirizine Hydrochloride Tablets due to ranitidine cross-contamination. This poses a serious risk of severe allergic reactions, including anaphylaxis, for hypersensitive individuals, prompting a nationwide alert from the FDA.

Health Business Medical Science Legal Education Product Recall Cetirizine Hydrochloride Ranitidine Unique Pharmaceutical Laboratories Cross-contamination Anaphylaxis FDA Food Recalls Drugs